NCT00737321

Brief Summary

This pilot study is designed to assess the impact of ischemia/ diminished wound vascularization and stress on wound healing by comparing patterns of gene expression in specific cell types critical to wound healing biology, e.g. macrophages or endothelial cells.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2008

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 19, 2008

Completed
10.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

December 1, 2021

Status Verified

November 1, 2021

Enrollment Period

10.3 years

First QC Date

August 15, 2008

Last Update Submit

November 18, 2021

Conditions

Keywords

Impact of ischemiaImpact of stress andIdentify patterns of gene expression

Outcome Measures

Primary Outcomes (1)

  • Changes in Gene Expression Profile in Healing versus Non-healing Wounds

    Wound tissue biopsies, saliva, serum samples and wound sponges will be obtained at an initial time point, at the midpoint of the study and near the end of wound closure over a 12 week window. If the wound closes quickly, i.e. less than 4 weeks then only 2 biopsies will be obtained.

    12 weeks

Study Arms (2)

2- Diabetics without wound (s)

These group of subject will be control arm, included who have good glycemic control diabetic with HbA1c 8.4 or lower and also without any open wounds. Samples will be collected.

Procedure: Samples will be collected

1-Subjects with diabetes with wound

This group of subjects will have wound and come for couple of follow up visits for saliva collection, biopsy collection and blood draw.

Interventions

wound tissue biopsy, blood samples, saliva collection and wound VAC sponge (if applicable).

2- Diabetics without wound (s)

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients (n=80)including controlled group will be recruited from the OSU outpatient wound care center located at Morehouse plaza and OSU East, OSU plastic surgery, OSU diabetic clinics.

You may qualify if:

  • Age 18-69 years
  • ischemic wound group
  • non-ischemic wound group
  • diabetes with good glycemic control
  • lower extremity wound

You may not qualify if:

  • Age greater ≥ 70 years
  • End stage renal disease
  • Unable to provide informed consent
  • Pregnant women
  • Therapeutically anticoagulated
  • Prisoners
  • Periwound TcOM \< 25mmHg
  • Spinal cord injury
  • Taking immunosuppressive medications
  • Individuals with current diagnosis of a major psychiatric illness (e.g.schizophrenia,psychosis)
  • Severe protein malnutrition- pre-albumin \< 10 mg/dl or albumin \< 2 g/dl
  • Diabetes with poor glucose control-defined as hgb A1c \> 8.4%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

OSU East Wound Care Center

Columbus, Ohio, 43205, United States

Location

OSU Comprehensive Wound Care Center Morehouse

Columbus, Ohio, 43221, United States

Location

Related Publications (1)

  • Beckrich K, Aronovitch SA. Hospital-acquired pressure ulcers: a comparison of costs in medical vs. surgical patients. Nurs Econ. 1999 Sep-Oct;17(5):263-71. No abstract available.

Biospecimen

Retention: SAMPLES WITH DNA

All participnts with wounds will have 3 mm punch biopsy performed twice or three times in the whole study period.Obtained tissue sample will be processed immidiately and frozen in liquid nitrogen.The tissue sample will transport to research lab for genomic analysis.

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Gayle Gordillo, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 15, 2008

First Posted

August 19, 2008

Study Start

August 1, 2008

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

December 1, 2021

Record last verified: 2021-11

Locations